Atlas Trials

Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Clinical trial NCT02713386 · COMPLETED

Trial details

NCT number
NCT02713386
Sponsor
NRG Oncology
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube High Grade Serous AdenocarcinomaFIGO Stage III Ovarian Cancer 2014FIGO Stage IIIA Ovarian Cancer 2014FIGO Stage IIIA1 Ovarian CancerFIGO Stage IIIA2 Ovarian CancerFIGO Stage IIIB Ovarian Cancer 2014FIGO Stage IIIC Ovarian Cancer 2014FIGO Stage IVA Ovarian Cancer 2014FIGO Stage IVB Ovarian Cancer 2014Ovarian Clear Cell Adenocarcinoma
Start date
2016-11-14
Primary completion
2021-09-30
Enrollment
147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.